Project title: SCREENING FOR LIVER FIBROSIS – POPULATION-BASED STUDY ACROSS EUROPEAN COUNTRIES
Acronym: LIVERSCREEN
Grant Agreement number: 847989
Start-date: 01/01/2020
End-date: 31/12/2025
Abstract: Liver cirrhosis is late-stage liver fibrosis (scarring) caused by liver diseases or conditions such as hepatitis B or C virus infection, obesity, type-2 diabetes mellitus or chronic alcoholism. There is no treatment to reverse advanced liver cirrhosis; it is always preceded by slowly developing, asymptomatic, liver fibrosis. Early diagnosis of liver fibrosis is crucial for the estimated 10 million Europeans with the undetected disease. The EU-funded LiverScreen project aims to develop a novel screening approach to identify asymptomatic liver fibrosis and cirrhosis among the general population. Researchers will identify groups at high risk of chronic liver disease and screen their liver stiffness with the innovative transient elastography technology. The 8 collaborating European countries will use 34 000 subjects to develop the screening and demonstrate its accuracy, clinical value, cost-effectiveness, acceptability and implementation potential
EUCORE’s role in the project: EUCORE is involved as subcontractor of the beneficiary Innovation ACTA, to provide support in reviewing ethics deliverables to comply with the European Union law and international legal sources, in particular with respect to the protection of personal data within research activities.
